This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Weetman AP (2007) Radioiodine treatment for benign thyroid diseases. Clin Endocrinol (Oxf) 66: 757–764
Marcocci C et al. (1990) A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13: 513–520
Velkeniers B et al. (1988) Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. Lancet 1: 1127–1129
Imseis RE et al. (1998) Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83: 685–687
Bonnema SJ et al. (2004) Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab 89: 4439–4444
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Razvi, S., Pearce, S. Do antithyroid drugs influence outcome after radioiodine therapy for hyperthyroidism?. Nat Rev Endocrinol 3, 628–629 (2007). https://doi.org/10.1038/ncpendmet0584
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0584